Literature DB >> 17882036

Automated measurement of hippocampal atrophy using fluid-registered serial MRI in AD and controls.

Josephine Barnes1, Emma B Lewis, Rachael I Scahill, Jonathan W Bartlett, Chris Frost, Jonathan M Schott, Martin N Rossor, Nick C Fox.   

Abstract

OBJECTIVE: To assess hippocampal atrophy rates calculated from fluid registration methods.
METHODS: Hippocampi were segmented on baseline and registered-repeat scans of 32 probable Alzheimer disease (AD) subjects and 55 controls. Fluid-based atrophy rates were calculated.
RESULTS: In AD patients, the mean (SD) atrophy rates for manual, fluidly propagated, and Jacobian methods were 5.09 (3.59), 5.34 (3.43), and 3.55 (2.70) (percentage per year). In controls, atrophy rates were 1.31 (2.00), 0.89 (0.75), and 0.56 (1.12) (percentage per year). In AD, fluid propagation and manual rates were similar in means (P = 0.55) and variances (P = 0.71). Jacobian rates were smaller in mean (P = 0.002) and variance (P = 0.026) than in manual rates. In controls, fluid-propagated rates were similar in mean to manual rates (P = 0.12), but less variable (P < 0.0001). Jacobian rates were smaller in mean (P = 0.014) and less variable (P < 0.0001) than in manual rates. Both fluid methods were superior to manual measures in separating AD from controls (P < 0.0001).
CONCLUSIONS: Fluid-based methods may be useful in large serial hippocampal studies.

Entities:  

Mesh:

Year:  2007        PMID: 17882036     DOI: 10.1097/rct.0b013e31802f4139

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN: 0363-8715            Impact factor:   1.826


  10 in total

Review 1.  Biomarkers in translational research of Alzheimer's disease.

Authors:  Rawan Tarawneh; David M Holtzman
Journal:  Neuropharmacology       Date:  2010-04-13       Impact factor: 5.250

2.  MRI-derived measurements of human subcortical, ventricular and intracranial brain volumes: Reliability effects of scan sessions, acquisition sequences, data analyses, scanner upgrade, scanner vendors and field strengths.

Authors:  Jorge Jovicich; Silvester Czanner; Xiao Han; David Salat; Andre van der Kouwe; Brian Quinn; Jenni Pacheco; Marilyn Albert; Ronald Killiany; Deborah Blacker; Paul Maguire; Diana Rosas; Nikos Makris; Randy Gollub; Anders Dale; Bradford C Dickerson; Bruce Fischl
Journal:  Neuroimage       Date:  2009-02-20       Impact factor: 6.556

3.  Baseline CSF p-tau levels independently predict progression of hippocampal atrophy in Alzheimer disease.

Authors:  W J P Henneman; H Vrenken; J Barnes; I C Sluimer; N A Verwey; M A Blankenstein; M Klein; N C Fox; P Scheltens; F Barkhof; W M van der Flier
Journal:  Neurology       Date:  2009-09-22       Impact factor: 9.910

4.  Alzheimer's disease neuroimaging initiative: a one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition.

Authors:  Alex D Leow; Igor Yanovsky; Neelroop Parikshak; Xue Hua; Suh Lee; Arthur W Toga; Clifford R Jack; Matt A Bernstein; Paula J Britson; Jeffrey L Gunter; Chadwick P Ward; Bret Borowski; Leslie M Shaw; John Q Trojanowski; Adam S Fleisher; Danielle Harvey; John Kornak; Norbert Schuff; Gene E Alexander; Michael W Weiner; Paul M Thompson
Journal:  Neuroimage       Date:  2009-04-15       Impact factor: 6.556

5.  Hippocampal atrophy rates in Alzheimer disease: added value over whole brain volume measures.

Authors:  W J P Henneman; J D Sluimer; J Barnes; W M van der Flier; I C Sluimer; N C Fox; P Scheltens; H Vrenken; F Barkhof
Journal:  Neurology       Date:  2009-03-17       Impact factor: 9.910

6.  Automated MRI parcellation of the frontal lobe.

Authors:  Marin E Ranta; Min Chen; Deana Crocetti; Jerry L Prince; Krish Subramaniam; Bruce Fischl; Walter E Kaufmann; Stewart H Mostofsky
Journal:  Hum Brain Mapp       Date:  2013-07-29       Impact factor: 5.038

7.  Automated cross-sectional and longitudinal hippocampal volume measurement in mild cognitive impairment and Alzheimer's disease.

Authors:  Kelvin K Leung; Josephine Barnes; Gerard R Ridgway; Jonathan W Bartlett; Matthew J Clarkson; Kate Macdonald; Norbert Schuff; Nick C Fox; Sebastien Ourselin
Journal:  Neuroimage       Date:  2010-03-15       Impact factor: 6.556

8.  Gray matter atrophy rate as a marker of disease progression in AD.

Authors:  Valerie M Anderson; Jonathan M Schott; Jonathan W Bartlett; Kelvin K Leung; David H Miller; Nick C Fox
Journal:  Neurobiol Aging       Date:  2010-12-15       Impact factor: 4.673

9.  MIRIAD--Public release of a multiple time point Alzheimer's MR imaging dataset.

Authors:  Ian B Malone; David Cash; Gerard R Ridgway; David G MacManus; Sebastien Ourselin; Nick C Fox; Jonathan M Schott
Journal:  Neuroimage       Date:  2012-12-28       Impact factor: 6.556

10.  Global gray matter changes in posterior cortical atrophy: a serial imaging study.

Authors:  Manja Lehmann; Josephine Barnes; Gerard R Ridgway; Natalie S Ryan; Elizabeth K Warrington; Sebastian J Crutch; Nick C Fox
Journal:  Alzheimers Dement       Date:  2012-02-23       Impact factor: 21.566

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.